161 related articles for article (PubMed ID: 18759693)
1. Peripheral thyrotropin receptor mRNA as a novel marker for differentiated thyroid cancer diagnosis and surveillance.
Barbosa GF; Milas M
Expert Rev Anticancer Ther; 2008 Sep; 8(9):1415-24. PubMed ID: 18759693
[TBL] [Abstract][Full Text] [Related]
2. Circulating thyroid cancer markers.
Gupta M; Chia SY
Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):383-8. PubMed ID: 17940468
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of peripheral thyrotropin receptor mRNA in follow-up of differentiated thyroid cancer.
Milas M; Barbosa GF; Mitchell J; Berber E; Siperstein A; Gupta M
Ann Surg Oncol; 2009 Feb; 16(2):473-80. PubMed ID: 19015922
[TBL] [Abstract][Full Text] [Related]
4. Detection of thyrotropin-receptor messenger ribonucleic acid (mRNA) and thyroglobulin mRNA transcripts in peripheral blood of patients with thyroid disease: sensitive and specific markers for thyroid cancer.
Chinnappa P; Taguba L; Arciaga R; Faiman C; Siperstein A; Mehta AE; Reddy SK; Nasr C; Gupta MK
J Clin Endocrinol Metab; 2004 Aug; 89(8):3705-9. PubMed ID: 15292293
[TBL] [Abstract][Full Text] [Related]
5. Thyroglobulin: a specific serum marker for the management of thyroid carcinoma.
Whitley RJ; Ain KB
Clin Lab Med; 2004 Mar; 24(1):29-47. PubMed ID: 15157556
[TBL] [Abstract][Full Text] [Related]
6. Circulating thyroglobulin mRNA does not predict early and midterm recurrences in patients undergoing thyroidectomy for cancer.
Lombardi CP; Bossola M; Princi P; Boscherini M; La Torre G; Raffaelli M; Traini E; Salvatori M; Pontecorvi A; Bellantone R
Am J Surg; 2008 Sep; 196(3):326-32. PubMed ID: 18614150
[TBL] [Abstract][Full Text] [Related]
7. Molecular detection of thyroglobulin mRNA transcripts in peripheral blood of patients with thyroid disease by RT-PCR.
Bojunga J; Röddiger S; Stanisch M; Kusterer K; Kurek R; Renneberg H; Adams S; Lindhorst E; Usadel KH; Schumm-Draeger PM
Br J Cancer; 2000 May; 82(10):1650-5. PubMed ID: 10817499
[TBL] [Abstract][Full Text] [Related]
8. Real time RT-PCR analysis of thyroglobulin mRNA in peripheral blood in patients with congenital athyreosis and with differentiated thyroid carcinoma after stimulation with recombinant human thyrotropin.
Kaufmann S; Schmutzler C; Schomburg L; Körber C; Luster M; Rendl J; Reiners C; Köhrle J
Endocr Regul; 2004 Jun; 38(2):41-9. PubMed ID: 15497927
[TBL] [Abstract][Full Text] [Related]
9. Challenges of serum thyroglobulin (Tg) measurement in the presence of Tg autoantibodies.
Spencer CA
J Clin Endocrinol Metab; 2004 Aug; 89(8):3702-4. PubMed ID: 15292292
[No Abstract] [Full Text] [Related]
10. Real-time quantitative PCR measurement of thyroglobulin mRNA in peripheral blood of thyroid cancer patients and healthy subjects.
Li D; Butt A; Clarke S; Swaminathana R
Ann N Y Acad Sci; 2004 Jun; 1022():147-51. PubMed ID: 15251954
[TBL] [Abstract][Full Text] [Related]
11. The additive clinical value of combined thyroglobulin and antithyroglobulin antibody measurements to define persistent and recurrent disease in patients with differentiated thyroid cancer.
Aras G; Gültekin SS; Küçük NO
Nucl Med Commun; 2008 Oct; 29(10):880-4. PubMed ID: 18769305
[TBL] [Abstract][Full Text] [Related]
12. Circulating thyrotropin receptor mRNA as a novel marker of thyroid cancer: clinical applications learned from 1758 samples.
Milas M; Shin J; Gupta M; Novosel T; Nasr C; Brainard J; Mitchell J; Berber E; Siperstein A
Ann Surg; 2010 Oct; 252(4):643-51. PubMed ID: 20881771
[TBL] [Abstract][Full Text] [Related]
13. Serum thyroglobulin measurement: clinical background and main methodological aspects with clinical impact.
Iervasi A; Iervasi G; Carpi A; Zucchelli GC
Biomed Pharmacother; 2006 Sep; 60(8):414-24. PubMed ID: 16959467
[TBL] [Abstract][Full Text] [Related]
14. [Standards, options and recommendations for blood tumor markers in thyroid cancers].
Pichon MF; Basuyau JP; Gory-Delabaere G; Eche N; Daver A; Blanc-Vincent MP; Riedinger JM; Deneux L; Bidart JM
Bull Cancer; 2001 Aug; 88(8):775-92. PubMed ID: 11578946
[TBL] [Abstract][Full Text] [Related]
15. The utility of peripheral thyrotropin receptor mRNA in the management of differentiated thyroid cancer.
Aliyev A; Soundararajan S; Bucak E; Gupta M; Hatipoglu B; Nasr C; Siperstein A; Berber E
Surgery; 2015 Oct; 158(4):1089-93; discussion 1093-4. PubMed ID: 26212344
[TBL] [Abstract][Full Text] [Related]
16. Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood.
Ringel MD; Ladenson PW; Levine MA
J Clin Endocrinol Metab; 1998 Dec; 83(12):4435-42. PubMed ID: 9851791
[TBL] [Abstract][Full Text] [Related]
17. Thyrotropin receptor/thyroglobulin messenger ribonucleic acid in peripheral blood and fine-needle aspiration cytology: diagnostic synergy for detecting thyroid cancer.
Wagner K; Arciaga R; Siperstein A; Milas M; Warshawsky I; Sethu S; Reddy K; Gupta MK
J Clin Endocrinol Metab; 2005 Apr; 90(4):1921-4. PubMed ID: 15687333
[TBL] [Abstract][Full Text] [Related]
18. Measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer.
Spencer CA; Lopresti JS
Nat Clin Pract Endocrinol Metab; 2008 Apr; 4(4):223-33. PubMed ID: 18268520
[TBL] [Abstract][Full Text] [Related]
19. Lessons from a review of thyroglobulin assays in the management of thyroid cancer.
Wong J; Lu Z; Doery J; Fuller P
Intern Med J; 2008 Jun; 38(6):441-4. PubMed ID: 18613899
[TBL] [Abstract][Full Text] [Related]
20. Thyroglobulin: current status in differentiated thyroid carcinoma (review).
Harish K
Endocr Regul; 2006 Jun; 40(2):53-67. PubMed ID: 17100547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
